Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Czubryt

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Canadian Journal of Physiology and Pharmacology|August 2, 2014
A tale of 2 tissues: the overlapping role of scleraxis in tendons and the heartMichael P Czubryt
Fibrogenesis & Tissue Repair|November 2, 2012
Common threads in cardiac fibrosis, infarct scar formation, and wound healingMichael P Czubryt
Journal of Cardiovascular Development and Disease|August 21, 2019
Cardiac Fibroblast to Myofibroblast Phenotype Conversion-An Unexploited Therapeutic TargetMichael P Czubryt
Cardiovascular & Hematological Disorders Drug Targets|May 8, 2014
Transcriptional control of collagen I gene expressionPatricia Roche, Michael P Czubryt
American Journal of Physiology. Cell Physiology|October 2, 2023
The role of fibrosis in the pathophysiology of muscular dystrophyFarnaz Mogharehabed, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology|December 24, 2009
Emerging concepts in cardiac matrix biologyLeon Espira, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology|August 4, 2012
Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteinsAlexandra Blant, Michael P Czubryt
Recent Progress in Hormone Research|January 30, 2004
Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophyMichael P Czubryt, Eric N Olson
Canadian Journal of Physiology and Pharmacology|March 9, 2017
A primer on current progress in cardiac fibrosisDanah Al Hattab, Michael P Czubryt
Cellular Signalling|June 19, 2021
Cardiac fibrosis: Pathobiology and therapeutic targetsMichael P Czubryt, Taben M Hale
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Canadian Journal of Physiology and Pharmacology|August 2, 2014
A tale of 2 tissues: the overlapping role of scleraxis in tendons and the heartMichael P Czubryt
Fibrogenesis & Tissue Repair|November 2, 2012
Common threads in cardiac fibrosis, infarct scar formation, and wound healingMichael P Czubryt
Journal of Cardiovascular Development and Disease|August 21, 2019
Cardiac Fibroblast to Myofibroblast Phenotype Conversion-An Unexploited Therapeutic TargetMichael P Czubryt
Cardiovascular & Hematological Disorders Drug Targets|May 8, 2014
Transcriptional control of collagen I gene expressionPatricia Roche, Michael P Czubryt
American Journal of Physiology. Cell Physiology|October 2, 2023
The role of fibrosis in the pathophysiology of muscular dystrophyFarnaz Mogharehabed, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology|December 24, 2009
Emerging concepts in cardiac matrix biologyLeon Espira, Michael P Czubryt
Canadian Journal of Physiology and Pharmacology|August 4, 2012
Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteinsAlexandra Blant, Michael P Czubryt
Recent Progress in Hormone Research|January 30, 2004
Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophyMichael P Czubryt, Eric N Olson
Canadian Journal of Physiology and Pharmacology|March 9, 2017
A primer on current progress in cardiac fibrosisDanah Al Hattab, Michael P Czubryt
Cellular Signalling|June 19, 2021
Cardiac fibrosis: Pathobiology and therapeutic targetsMichael P Czubryt, Taben M Hale
Pageof 6